Latest from ASM Communications
Consortium will provide research- and evidence-based resources for addressing issues of sexual harassment to other professional organizations.
Infections with a Human Papillomavirus (HPV) cause 99 percent of cervical cancer cases, and the disease’s first sign is often the appearance of precancerous lesions on a woman's cervix. But bacteria may play an important role, too. New research suggests that the cervical microbiome may influence HPV infection more than researchers previously thought.
A new antimicrobial-resistance gene, VCC-1, a ß-lactamase gene, has been discovered in benign close relatives of virulent Vibrio cholerae, which causes cholera. Now, a team of Canadian researchers has found a way to block the VCC-1 enzyme, which disables that resistance gene. The research is published February 19th in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much lower tendency to develop resistance, and it remains in the tissues where the Mycobacterium tuberculosis bacteria reside for longer, killing them more effectively.
Acarbose, a drug commonly used to treat type II diabetes, can change the gut microbiome in a reversible and diet-dependent manner, according to new research published in the journal mSphere. The findings highlight the importance of the gut microbiome in health and show that more attention should be paid to how the gut microbiome responds to medications.